Healthcare
Glaukos Corporation
GKOSPrice is delayed.
About Glaukos Corporation
Glaukos makes medical devices and drugs used by eye doctors to treat glaucoma, a disease that damages the optic nerve and can cause blindness if untreated. Their main products are tiny stents that doctors implant during eye surgery to help fluid drain from the eye and reduce pressure inside it. The company also develops medications and devices to treat other eye conditions like corneal scarring and age-related macular degeneration, which causes vision loss in older people. They sell to hospitals, surgery centers, and eye doctor offices.
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
- What each number means, in plain English, with the Wall Street name where the two differ.
- A plain-English summary of the company.
- How many analysts cover it, and the count behind each rating.
- Recent news, dated.
Get the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Look up another company
Related Research
More Healthcare stocks to explore